Theravance Biopharma Inc
TBPH
|
|
| |
|
| Trading Volume | 2,718 |
|
|
11.59 - 7.66 |
| Market Cap Full | $ 409.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -1.3% | -20.3% | -3.3% | -13.5% |
| Q2 | - | -7.9% | -4.6% | -5.2% |
| Q3 | - | -18.7% | -16.6% | 11.9% |
| Q4 | - | -5.8% | 29.5% | 10.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -15.7 | -0.1 | -5.4 | 4.3 | -7.6 | -3.8 | 21.8 | -18.7 | - | - | - | - |
| 2023 | |||||||||||
| -3.7 | -0.1 | 0.5 | -0.2 | 3.2 | -7.4 | -4.4 | -3.7 | -9.4 | 9.4 | 11 | 7.3 |
| 2022 | |||||||||||
| -17.6 | 14.2 | -8.1 | 1.4 | -9.4 | 3.2 | -3 | 2.8 | 12.2 | -1.7 | 7.9 | 4.3 |
| 2021 | |||||||||||
| 6 | -11 | 23 | -2.7 | -13 | -16 | -10.6 | -36.1 | -10.8 | 9.9 | 3.3 | 31.6 |
| 2020 | |||||||||||
| 7.1 | -16.1 | -1.7 | 26.2 | -13.4 | -16.9 | -7.5 | -5.6 | -19.3 | 27.9 | -12.3 | 5.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.4 | -0.3 | -1.2 | -1.4 |
| Q2 | -0.3 | -0.1 | -0.8 | -1 |
| Q3 | -0.2 | 12.1 | -0.5 | -1.2 |
| Q4 | 0 | 0.2 | -0.4 | -0.9 |
| A | -0.8 | 11.9 | -2.9 | -4.5 |